Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent
Open accessThe DOI matches its Crossref record; 82 of the 84 references it cites were found in a registry or an index.
Abstract
Idiopathic pulmonary fibrosis (IPF) is a destructive inflammatory disease with limited therapeutic options. To better understand the inflammatory responses that precede and concur with collagen deposition, we used three models of pulmonary fibrosis and identify a critical mechanistic role for IL-17A. After exposure to bleomycin (BLM), but not Schistosoma mansoni eggs, IL-17A produced by CD4+ and γδ+ T cells induced significant neutrophilia and pulmonary fibrosis. Studies conducted with C57BL/6 il17a−/− mice confirmed an essential role for IL-17A. Mechanistically, using ifnγ−/−, il10−/−, il10−/−il12p40−/−, and il10−/−il17a−/− mice and TGF-β blockade, we demonstrate that IL-17A–driven fibrosis is suppressed by IL-10 and facilitated by IFN-γ and IL-12/23p40. BLM-induced IL-17A production was also TGF-β dependent, and recombinant IL-17A–mediated fibrosis required TGF-β, suggesting cooperative roles for IL-17A and TGF-β in the development of fibrosis. Finally, we show that fibrosis induced by IL-1β, which mimics BLM-induced fibrosis, is also highly dependent on IL-17A. IL-17A and IL-1β were also increased in the bronchoalveolar lavage fluid of patients with IPF. Together, these studies identify a critical role for IL-17A in fibrosis, illustrating the potential utility of targeting IL-17A in the treatment of drug and inflammation-induced fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-17A increases and stabilizes TGF-βRII expression on fibroblasts, thereby enhancing their sensitivity to TGF-β120”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [120]
In the citing paper
“the functions of IL-17 include stimulation of ECM production, collagen disposition, and mediation of TGF-β signaling (144).”
From The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis (2018) · cites this paper as [144]
In the citing paper
“murine studies in which administration of IL-17A is sufficient to induce collagen accumulation and fibrotic lesions (144, 145)”
From The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis (2018) · cites this paper as [144]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992 · cited 6×
“More recently, studies have also suggested important inflammatory activities for TGF, with TGF providing an integral differentiation signal for the develop ment of proinflammatory IL17A–secreting cells (Bettelli et al., 2006; Veldhoen et al., 2006).”
BackgroundResultInfluentialCellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
Self-citationIL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099 · cited 5×
“These observations also suggest that IL10 inhibits the development of BLMinduced fibrosis by targeting the proinflammatory IL23–IL17A pathway rather than the IL12–IFN axis.”
BackgroundInfluentialVeldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605 · cited 3×
“However, recent studies demonstrated that TGF is also critically involved in the development of IL17A–producing lymphocytes (Bettelli et al., 2006; Veldhoen et al., 2006), which regulate the development of a variety of inflammatory and autoimmune diseases (Tesmer et al., 2008).”
BackgroundSutton, C. E., Lalor, S. J., Sweeney, C. M., Brereton, C. F., Lavelle, E. C., & Mills, K. H. G. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.001 · Cited by 1,553 · cited 3×
“Similarly, IL1 can stimulate IL17A production (Sutton et al., 2009), and IL1 is a critical mediator of pulmonary fibrosis (Gasse et al., 2007).”
BackgroundMcGeachy, M. J., Bak-Jensen, K. S., Chen, Y., Tato, C. M., Blumenschein, W., McClanahan, T., & Cua, D. J. (2007) · Nature Immunology · doi:10.1038/ni1539 · Cited by 1,520 · cited 3×
“Similar to previ ous studies (McGeachy et al., 2007; Stumhofer et al., 2007), IL10 was often coexpressed with IL17A and RoRt, sug gesting that Th17 cells may develop into IL10–secreting cells to limit Th17 effector function.”
ResultInduction and effector functions of TH17 cells
Bettelli, E., Korn, T., Oukka, M., & Kuchroo, V. K. (2008) · Nature · doi:10.1038/nature07036 · Cited by 1,216 · cited 2×
“, 2006), which regulate the pathogenesis of a variety of autoimmune and inflammatory diseases (Bettelli et al., 2008).”
BackgroundTesmer, L. A., Lundy, S. K., Sarkar, S., & Fox, D. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00628.x · Cited by 1,102
Nakae, S., Komiyama, Y., Nambu, A., Sudo, K., Iwase, M., Homma, I., Sekikawa, K., Asano, M., & Iwakura, Y. (2002) · Immunity · doi:10.1016/s1074-7613(02)00391-6 · Cited by 1,052 · cited 1×
“However, IL17A has been implicated in IL13– associated airway hyperreactivity (Nakae et al., 2002).”
BackgroundOrtiz, L. A., DuTreil, M., Fattman, C., Pandey, A. C., Torres, G., Go, K., & Phinney, D. G. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704421104 · Cited by 1,019 · cited 1×
“These observations are consistent with studies that suggested IL10 could regulate the magnitude and effec tor function of Th17 responses (Fitzgerald et al., 2007; McGeachy et al., 2007; Chang et al., 2008).”
Result
Cited by
Items 101–200 of 751
Roberson, E. C., Tully, J. E., Guala, A. S., Reiss, J. N., Godburn, K. E., Pociask, D. A., Alcorn, J. F., Riches, D. W. H., Dienz, O., Janssen-Heininger, Y. M. W., et al. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0460oc · Cited by 135
“Interestingly, a recent report demonstrated that IL-17A produced by TH17 cells can mediate fibrosis in mice (39).”
BackgroundPeng, X., Xiao, Z., Zhang, J., Li, Y., Dong, Y., & Du, J. (2015) · The Journal of Pathology · doi:10.1002/path.4430 · Cited by 127
“Bleomycin- or IL-1β-induced pulmonary fibrosis is also dependent on IL-17A produced by γδ T and Th17 cells [21].”
BackgroundPlatelet-derived growth factor-producing CD4+ Foxp3+ regulatory T lymphocytes promote lung fibrosis
Lo Re, S., Lecocq, M., Uwambayinema, F., Yakoub, Y., Delos, M., Demoulin, J.-B., Lucas, S., Sparwasser, T., Renauld, J.-C., Lison, D., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201103-0516oc · Cited by 128
“Recently, experimental studies clarified the role of Th17 lymphocytes, another proinflammatory T eff lymphocyte subset, and showed that the Th17 cytokine IL-17A plays a crucial role in IL-1b-, infection-, and bleomycin-induced lung fibrosis in mice (11, 47).”
Guillot, A., Hamdaoui, N., Bizy, A., Zoltani, K., Souktani, R., Zafrani, E.-S., Mallat, A., Lotersztajn, S., & Lafdil, F. (2014) · Hepatology · doi:10.1002/hep.26598 · Cited by 127
“These data are in line with recent studies describing the profibrogenic properties of IL-17 in different experimental models of liver, pulmonary, or myocardial fibrosis by direct effects on myofibroblasts or indirectly by release of proinflammatory and fibrogenic cytokines from macrophages.(10,13,14,32) Interestingly,…”
ResultImmune Mechanisms of Pulmonary Fibrosis with Bleomycin
Ishida, Y., Kuninaka, Y., Mukaida, N., & Kondo, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043149 · Cited by 136
Nuovo, G. J., Hagood, J. S., Magro, C. M., Chin, N., Kapil, R., Davis, L., Marsh, C. B., & Folcik, V. A. (2012) · Modern Pathology · doi:10.1038/modpathol.2011.166 · Cited by 123
“Some insights into understanding the course of pulmonary fibrosis have come from animal models of bleomycin-mediated lung injury, revealing participation of inflammatory mediators (11), hematopoietic progenitors (12, 13) and chemokines that attract cells into the sites of injury (14).”
BackgroundImmune mechanisms in fibrotic interstitial lung disease
Kamiya, M., Carter, H. M., Espíndola, M. S., Doyle, T. J., Lee, J. S., Merriam, L. T., Zhang, F., Kawano-Dourado, L. B., Sparks, J. A., Hogaboam, C. M., et al. (2024) · Cell · doi:10.1016/j.cell.2024.05.015 · Cited by 141
Yun, S., Kim, S., & Kim, E. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00162 · Cited by 130
“IL-17A-mediated fibrosis required TGF-β in an animal model of pulmonary fibrosis (Wilson et al., 2010).”
BackgroundNovel mechanisms and clinical trial endpoints in intestinal fibrosis*
Wang, J., Lin, S., Brown, J. M., van Wagoner, D., Fiocchi, C., & Rieder, F. (2021) · Immunological Reviews · doi:10.1111/imr.12974 · Cited by 115
Fra-2–expressing macrophages promote lung fibrosis
Ucero, A. C., Bakiri, L., Roediger, B., Suzuki, M., Jiménez, M., Mandal, P., Braghetta, P., Bonaldo, P., Paz-Ares, L. G., Torre, C. F., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125366 · Cited by 131
Oh, K., Park, H.-B., Byoun, O.-J., Shin, D.-M., Jeong, E. M., Kim, Y. W., Kim, Y. S., Melino, G., Kim, I.-G., & Lee, D.-S. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101457 · Cited by 118
“It further appears that the Th17 response may play an important role in the amplification of the inflammatory response after noninfectious pulmonary injury (Lo Re et al., 2010; Sonnenberg et al., 2010; Wilson et al., 2010).”
BackgroundResultInfluentialThe interplay of DAMPs, TLR4, and proinflammatory cytokines in pulmonary fibrosis
Bolourani, S., Brenner, M., & Wang, P. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02113-y · Cited by 134
Non-invasive Imaging of Idiopathic Pulmonary Fibrosis Using Cathepsin Protease Probes
Withana, N. P., Ma, X., McGuire, H. M., Verdoes, M., van der Linden, W. A., Ofori, L. O., Zhang, R., Li, H., Sanman, L. E., Wei, K., et al. (2016) · Scientific Reports · doi:10.1038/srep19755 · Cited by 113
Liu, Y., Zhu, H., Su, Z., Sun, C., Yin, J., Yuan, H., Sandoghchian, S., Jiao, Z., Wang, S., & Xu, H. (2012) · International Immunology · doi:10.1093/intimm/dxs056 · Cited by 110
The role of interleukin 17 in Crohn’s disease-associated intestinal fibrosis
Biancheri, P., Pender, S. L. F., Ammoscato, F., Giuffrida, P., Sampietro, G. M., Ardizzone, S., Ghanbari, A., Curciarello, R., Pasini, A., Monteleone, G., et al. (2013) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-6-13 · Cited by 110
“In particular, IL-1β-induced and bleomycin-induced lung fibrosis seems to depend on the action of IL-17A, and in addition, IL-17A mice are less susceptible to experimental skin fibrosis [7,24].”
BackgroundMia, M. M., Boersema, M., & Bank, R. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091559 · Cited by 109
“Like various organ fibrosis, lung and skin fibrosis are mediated by the IL1b [6,7,8].”
BackgroundB cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis
François, A., Gombault, A., Villeret, B., Alsaleh, G., Fanny, M., Gasse, P., Adam, S. M., Crestani, B., Sibilia, J., Schneider, P., et al. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.08.003 · Cited by 109
“In the BLM model, IL-1β and IL-17A are expressed early and mediate late fibrosis[19,38].”
BackgroundKulkarni, O. P., Lichtnekert, J., Anders, H., & Mulay, S. R. (2016) · Mediators of Inflammation · doi:10.1155/2016/2856213 · Cited by 128
“Group 3 ILCs promoted bleomycin-induced pulmonary fibrosis by secreting IL-17 [130, 131], whereas IL25 induced expansion of the group 2 ILCs within the lungs, which promoted pulmonary fibrosis via IL-13 dependent mechanism [132].”
BackgroundNi, K., Liu, M., Zheng, J. H., Wen, L., Chen, Q., Xiang, Z., Lam, K.-T., Liu, Y., Chan, G., Lau, Y., et al. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0326oc · Cited by 111
The Roles of IL-1 Family Cytokines in the Pathogenesis of Systemic Sclerosis
Xu, D., Mu, R., & Wei, X. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02025 · Cited by 106
Valente, A. J., Yoshida, T., Gardner, J. D., Somanna, N., Delafontaine, P., & Chandrasekar, B. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2011.10.010 · Cited by 107
Truchetet, M., Brembilla, N. C., Montanari, E., Lonati, P. A., Raschi, E., Zeni, S., Fontao, L., Meroni, P. L., & Chizzolini, C. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37860 · Cited by 109
Acute Lung Injury: IL-17A-Mediated Inflammatory Pathway and Its Regulation by Curcumin
Gouda, M. M., & Bhandary, Y. P. (2019) · Inflammation · doi:10.1007/s10753-019-01010-4 · Cited by 110
Gochuico, B. R., Huizing, M., Golas, G. A., Scher, C. D., Tsokos, M., Denver, S. D., Frei‐Jones, M. J., & Gahl, W. A. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00198 · Cited by 105
“These findings are relevant, because these profibrotic proteins may have cooperative roles in development of fibrosis in general (28,29).”
BackgroundSelf-citationCong, L., Li, T., Wang, H., Wu, Y., Wang, S., Zhao, Y., Zhang, G., & Duan, J. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15475 · Cited by 104
RetractedOishi, K., Mimura‐Kimura, Y., Miyasho, T., Aoe, K., Ogata, Y., Katayama, H., Murata, Y., Ueoka, H., Matsumoto, T., & Mimura, Y. (2012) · Cytokine · doi:10.1016/j.cyto.2012.08.032 · Cited by 104
IL-36α Exerts Pro-Inflammatory Effects in the Lungs of Mice
Ramadas, R. A., Ewart, S., Iwakura, Y., Medoff, B. D., & LeVine, A. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045784 · Cited by 105
Spontaneous Chitin Accumulation in Airways and Age-Related Fibrotic Lung Disease
Van Dyken, S. J., Liang, H.-E., Naikawadi, R. P., Woodruff, P. G., Wolters, P. J., Erle, D. J., & Locksley, R. M. (2017) · Cell · doi:10.1016/j.cell.2017.03.044 · Cited by 104
The metabolism-modulating activity of IL-17 signaling in health and disease
Bechara, R., McGeachy, M. J., & Gaffen, S. L. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20202191 · Cited by 104
Brembilla, N. C., Montanari, E., Truchetet, M.-E., Raschi, E., Meroni, P., & Chizzolini, C. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4334 · Cited by 95
“IL-17A has been shown to participate in the development of skin and lung fibrosis induced by bleomycin in mice [29,30].”
BackgroundResultThe Role of Mesenchymal Stem Cells in Radiation-Induced Lung Fibrosis
Zanoni, M., Cortesi, M., Zamagni, A., & Tesei, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163876 · Cited by 102
“In addition to Th2 response, the CD4+ IL-17-producing cell subpopulation (Th17), represents an emerging driver of lung fibrosis [54,71,72].”
BackgroundEmerging roles of innate lymphoid cells in inflammatory diseases: Clinical implications
Kortekaas Krohn, I., Shikhagaie, M. M., Golebski, K., Bernink, J. H., Breynaert, C., Creyns, B., Diamant, Z., Fokkens, W. J., Gevaert, P., Hellings, P., et al. (2018) · Allergy · doi:10.1111/all.13340 · Cited by 96
Vascular permeability in the fibrotic lung
Probst, C. K., Montesi, S. B., Medoff, B. D., Shea, B. S., & Knipe, R. S. (2020) · European Respiratory Journal · doi:10.1183/13993003.00100-2019 · Cited by 94
Reprogramming of profibrotic macrophages for treatment of bleomycin‐induced pulmonary fibrosis
Zhang, F., Ayaub, E. A., Wang, B., Puchulu‐Campanella, E., Li, Y., Hettiarachchi, S. U., Lindeman, S. D., Luo, Q., Rout, S., Srinivasarao, M., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202012034 · Cited by 108
“…THP-1 cells with IL-4, IL-13 plus IL-6 and examined the mRNA levels of both an M2 polarization marker (CD206) and two classic profibrotic cytokines (CCL18, IL-1b) (Prasse et al, 2006; Wilson et al, 2010) following incubation in the presence and absence of a potent TLR7 agonist (i.e., TLR7-54; ref.”
BackgroundSelf-citationLang, N. J., Gote-Schniering, J., Porras-Gonzalez, D., Yang, L., Sadeleer, L. D., Jentzsch, R. C., Shitov, V. A., Zhou, S., Ansari, M., Agami, A., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adh0908 · Cited by 104
Modern Concepts on the Role of Inflammation in Pulmonary Fibrosis
Homer, R. J., Elias, J. A., Lee, C. G., & Herzog, E. (2011) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2010-0296-ra.1 · Cited by 92
The cytokines of pulmonary fibrosis: Much learned, much more to learn
Luzina, I. G., Todd, N. W., Sundararajan, S., & Atamas, S. P. (2014) · Cytokine · doi:10.1016/j.cyto.2014.11.008 · Cited by 100
Mesenchymal cell survival in airway and interstitial pulmonary fibrosis
Bonner, J. C. (2010) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-3-15 · Cited by 98
“IL-1b overexpression in mice causes pulmonary fibrosis [83], and more recent work shows that IL-1b enhances bleomycin-induced fibrosis by upregulating IL-17A [84].”
BackgroundLiu, H., Mi, S., Li, Z., Hua, F., & Hu, Z.-W. (2013) · Autophagy · doi:10.4161/auto.24039 · Cited by 91
“found that interleukin-17A (IL17A) induces pulmonary fibrosis and knockdown of IL17A receptor reduces pulmonary fibrosis.(7) Our recent studies indicate that IL17A promotes the development and”
BackgroundPulmonary inflammation and fibroblast immunoregulation: from bench to bedside
Ghonim, M. A., Boyd, D. F., Flerlage, T., & Thomas, P. G. (2023) · Journal of Clinical Investigation · doi:10.1172/jci170499 · Cited by 95
Park, M.-J., Moon, S.-J., Lee, E.-J., Jung, K.-A., Kim, E.-K., Kim, D.-S., Lee, J.-H., Kwok, S.-K., Min, J.-K., Park, S.-H., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01611 · Cited by 89
Tissue-specific immunity in helminth infections
Vacca, F., & Le Gros, G. (2022) · Mucosal Immunology · doi:10.1038/s41385-022-00531-w · Cited by 86
Role of IL-17A and neutrophils in fibrosis in experimental hypersensitivity pneumonitis
Hasan, S. A., Eksteen, B., Reid, D., Paine, H. V., Alansary, A., Johannson, K., Gwozd, C., Goring, K.-A. R., Vo, T., Proud, D., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.01.015 · Cited by 88
Paquissi, F. C. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00490 · Cited by 95
“In addition, the role of the IL-17 axis in fibrogenesis has been shown in organs other than the liver, including the heart (119, 120), lung (121), and kidney (122).”
BackgroundTsukui, T., Ueha, S., Abe, J., Hashimoto, S.-I., Shichino, S., Shimaoka, T., Shand, F. H. W., Arakawa, Y., Oshima, K., Hattori, M., et al. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.06.005 · Cited by 94
Lin, S., Mao, R., Qian, C., Bettenworth, D., Wang, J., Li, J., Bruining, D. H., Jairath, V., Feagan, B. G., Chen, M., et al. (2021) · Physiological Reviews · doi:10.1152/physrev.00005.2021 · Cited by 91
Emerging role of immune cells as drivers of pulmonary fibrosis
Mutsaers, S. E., Miles, T., Prêle, C. M., & Hoyne, G. F. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108562 · Cited by 96
Vittal, R., Fan, L., Greenspan, D. S., Mickler, E. A., Gopalakrishnan, B., Gu, H., Benson, H. L., Zhang, C., Burlingham, W. J., Cummings, O. W., et al. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00080.2012 · Cited by 90
Hung, L., Sen, D., Oniskey, T. K., Katzen, J. B., Cohen, N. A., Vaughan, A. E., Nieves, W., Urisman, A., Beers, M. F., Krummel, M. F., et al. (2018) · Mucosal Immunology · doi:10.1038/s41385-018-0096-2 · Cited by 88
The protective role of TLR6 in a mouse model of asthma is mediated by IL-23 and IL-17A
Moreira, A. P., Cavassani, K. A., Ismailoglu, U. B., Hullinger, R., Dunleavy, M. P., Knight, D. A., Kunkel, S. L., Uematsu, S., Akira, S., & Hogaboam, C. M. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44999 · Cited by 83
“In addition, IL-17A drives neutrophil-mediated pulmonary fibrosis in a model of bleomycin-induced fibrosis (44).”
BackgroundRole of IL-17 family cytokines in the progression of IPF from inflammation to fibrosis
Nie, Y., Wu, S., Xuan, Y.-H., & Yan, G. (2022) · Military Medical Research · doi:10.1186/s40779-022-00382-3 · Cited by 103
CD4+CD25hiFoxp3+ Cells Exacerbate Bleomycin-Induced Pulmonary Fibrosis
Birjandi, S. Z., Palchevskiy, V., Xue, Y., Nuñez, S., Kern, R. M., Weigt, S. S., Lynch, J. P., Chatila, T. A., & Belperio, J. A. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.03.020 · Cited by 89
Regulatory Immune Cells in Idiopathic Pulmonary Fibrosis: Friends or Foes?
van Geffen, C., Deißler, A., Quante, M., Renz, H. E., Hartl, D., & Kolahian, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.663203 · Cited by 88
“Th2 immune responses were shown to stimulate myofibroblasts and the progression of the disease through the production of IL-4, IL-5, IL-13 and IL-17A (95, 96).”
BackgroundFibroblast biology in pterygia
Kim, K. W., Park, S. H., & Kim, J. C. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.01.010 · Cited by 86
IL‐17A deficiency mitigates bleomycin‐induced complement activation during lung fibrosis
Cipolla, E., Fisher, A. J., Gu, H., Mickler, E. A., Agarwal, M., Wilke, C. A., Kim, K. K., Moore, B. B., & Vittal, R. (2017) · The FASEB Journal · doi:10.1096/fj.201700289r · Cited by 89
“(4) have shown that BLEO-injured lungs have high levels of IL-17A.”
BackgroundResultInfluentialCytokines in chronic respiratory diseases
Atamas, S. P., Chapoval, S. P., & Keegan, A. D. (2013) · F1000 Biology Reports · doi:10.3410/b5-3 · Cited by 92
Regulation and Relevance of Myofibroblast Responses in Idiopathic Pulmonary Fibrosis
Moore, M. W., & Herzog, E. L. (2013) · Current Pathobiology Reports · doi:10.1007/s40139-013-0017-8 · Cited by 89
Type 2 Immune Mechanisms in Carbon Nanotube-Induced Lung Fibrosis
Dong, J., & Ma, Q. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01120 · Cited by 83
“In the cases of bacterial and viral infections and bleomycin toxicity, an IL-1- and IL-17A-associated mechanism is activated to propagate the TGF-β1 pathway, forming an IL-1– IL-17–TGF-β1 axis that serves as a major driver of fibrosis during sustained type 1- and Th17-driven inflammatory responses (45).”
Dufour, A. M., Alvarez, M., Russo, B., & Chizzolini, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01865 · Cited by 73
LOXL2—A New Target in Antifibrogenic Therapy?
Puente, A., Fortea, J. I., Cabezas, J., Arias Loste, M. T., Iruzubieta, P., Llerena, S., Huelin, P., Fábrega, E., & Crespo, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071634 · Cited by 79
Multiple Exposures to Ascaris suum Induce Tissue Injury and Mixed Th2/Th17 Immune Response in Mice
Nogueira, D. S., Gazzinelli-Guimarães, P. H., Barbosa, F. S., Resende, N. M., Silva, C. C., de Oliveira, L. M., Amorim, C. C. O., Oliveira, F. M. S., Mattos, M. S., Kraemer, L. R., et al. (2016) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0004382 · Cited by 76
Teng, F., Li, M., & Yu, J. (2020) · BMC Medicine · doi:10.1186/s12916-020-01718-3 · Cited by 86
“demonstrated that IL-17A gene knockout could decrease the severity of lung injury in mice, demonstrating the important role of IL-17A in fibrosis and inflammation [62].”
BackgroundT cells in idiopathic pulmonary fibrosis: crucial but controversial
Deng, L., Huang, T., & Zhang, L. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01344-x · Cited by 74
“IL-22 shows no significant variations in patients with IPF compared to normal individuals [60].”
BackgroundKainthola, A., Haritwal, T., Tiwari, M., Gupta, N., Parvez, S., Tiwari, M., Prakash, H., & Agrawala, P. K. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00506 · Cited by 83
“demonstrated that the severity of lung injury in mice was significantly decreased after mice IL-17A gene knockout, which proves the potent role of IL-17A in inflammation and fibrosis (28).”
BackgroundCritical Role for IL-18 in Spontaneous Lung Inflammation Caused by Autophagy Deficiency
Abdel Fattah, E., Bhattacharya, A., Herron, A., Safdar, Z., & Eissa, N. T. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402277 · Cited by 77
“Another important finding in our study is the increase of basal levels of TGF-b and IL-6 in the BAL of Atg7D mice.”
BackgroundInfluentialThe development of colitis in Il10 mice is dependent on IL-22
Gunasekera, D. C., Ma, J., Vacharathit, V., Shah, P. M., Ramakrishnan, A., Uprety, P., Shen, Z., Sheh, A., Brayton, C. F., Whary, M. T., et al. (2020) · Mucosal Immunology · doi:10.1038/s41385-019-0252-3 · Cited by 81
“Similarly, Il10−/−Il17a −/− mice were previously generated but neither the Helicobacter status nor the incidence of intestinal disease was reported although these studies were focused on IL-17A’s role in lung pathology (88, 89).”
BackgroundVittal, R., Mickler, E. A., Fisher, A. J., Zhang, C., Rothhaar, K., Gu, H., Brown, K. M., Emtiazdjoo, A., Lott, J. M., Frye, S. B., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076451 · Cited by 77
“We have previously demonstrated lung allograft rejection is in part mediated by anti-col(V) immunity and that col(V)-induced tolerance abrogated the rejection response [28] and Wilson and colleagues had reported that bleomycin-induced lung fibrosis may be T cell dependent [29].”
BackgroundIL-17A Promotes Initiation and Development of Intestinal Fibrosis Through EMT
Zhang, H., Zhang, Y.-N., Zhou, H., Guan, L., Li, Y., & Sun, M. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5234-x · Cited by 81
Chen, G., Ribeiro, C. M. P., Sun, L. V., Okuda, K., Kato, T., Gilmore, R. C., Martino, M. B., Dang, H., Abzhanova, A., Lin, J. M., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201810-1972oc · Cited by 82
“IL-1b Triggers UPR and Mucin Gene Expression in Airway Epithelia To evaluate induction of the ERN2–XBP1S cascade in a mucus overproduction disease context, primary HAE cells were exposed for 24 hours to recombinant human IL-1b (a proinflammatory/profibrotic cytokine associated with fibrosis in mouse [30] and human IPF…”
MethodThe Role of Dimethylarginine Dimethylaminohydrolase in Idiopathic Pulmonary Fibrosis
Pullamsetti, S. S., Savai, R., Dumitrascu, R., Dahal, B. K., Wilhelm, J., Königshoff, M., Zakrzewicz, D., Ghofrani, H. A., Weißmann, N., Eickelberg, O., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001725 · Cited by 82
“Neutrophil alterations are implicated in lung fibrosis (48), and recently, a possible role for IL-17–dependent pathogenic mechanisms has been discussed (49).”
BackgroundMacrophages: The Potent Immunoregulatory Innate Immune Cells
Kumar, V. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.88013 · Cited by 90
Amatya, N., Childs, E. E., Cruz, J. A., Aggor, F. E. Y., Garg, A. V., Berman, A. J., Gudjonsson, J. E., Atasoy, U., & Gaffen, S. L. (2018) · Science Signaling · doi:10.1126/scisignal.aat4617 · Cited by 75
Chen, Y., Li, C., Weng, D., Song, L., Tang, W., Dai, W., Yu, Y., Liu, F., Zhao, M., Lu, C., et al. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.11.012 · Cited by 75
“Some studies have demonstrated the pivotal function of IL-1β in promoting Th17 differentiation (Coccia et al., 2012; Gasse et al., 2011; Wilson et al., 2010).”
Regulation and function of innate and adaptive interleukin‐17‐producing cells
Hirota, K., Ahlfors, H., Duarte, J. H., & Stockinger, B. (2012) · EMBO reports · doi:10.1038/embor.2011.248 · Cited by 74
“Furthermore, pulmonary IL-17-producing γδ T cells and T H 17 cells promote lung fibrosis through increased syn thesis and secretion of collagen with neutrophilia in bleomycin-exposed mice (Mi et al , 2011; Wilson et al , 2010).”
Idiopathic pulmonary fibrosis (IPF) signaling pathways and protective roles of melatonin
Hosseinzadeh, A., Javad-Moosavi, S. A., Reiter, R. J., Hemati, K., Ghaznavi, H., & Mehrzadi, S. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.03.032 · Cited by 77
“indirectly induces pulmonary fibrosis by induction of other mediators such as TGF-β, IL-17 A and PDGF [52,53].”
BackgroundInfluentialRole of Th17 cells and IL-17 in lung transplant rejection
Shilling, R. A., & Wilkes, D. S. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0257-9 · Cited by 80
“Studies linking IL-17 to the development of fibrosis in humans and in patients with chronic rejection after lung transplantation suggest that IL17 may be a critical mediator of obliterative fibrosis of the airways [5, 51].”
BackgroundIs there a role for IL-17 in the pathogenesis of systemic sclerosis?
Chizzolini, C., Dufour, A. M., & Brembilla, N. C. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.09.007 · Cited by 76
Sex Hormones and Lung Inflammation
Reyes-García, J., Montaño, L. M., Carbajal-García, A., & Wang, Y.-X. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-68748-9_15 · Cited by 65
Ardain, A., Porterfield, J. Z., Kløverpris, H. N., & Leslie, A. J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00092 · Cited by 74
Wang, Y., Lou, D. W., Li, D., Jiang, W., Dong, J., Gao, W., & Chen, H. (2020) · Oncology Letters · doi:10.3892/ol.2020.11618 · Cited by 75
“Considering its essential role in mediating several acute and chronic respiratory pathologies, such as asthma (35) and idiopathic pulmonary fibrosis (36,37), it may be hypothesized that IL-17A may participate in the autoimmune-pathological processes involved in CIP.”
BackgroundResearch progress on drugs targeting the TGF-β signaling pathway in fibrotic diseases
Shi, N., Wang, Z., Zhu, H., Liu, W., Zhao, M., Jiang, X., Zhao, J., Ren, C., Zhang, Y., & Luo, L. (2022) · Immunologic Research · doi:10.1007/s12026-022-09267-y · Cited by 78
The role of interleukin-17 in inflammation-related cancers
Zhang, X., Li, B., Lan, T., Chiari, C. C., Ye, X., Wang, K., & Chen, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1479505 · Cited by 88
FIZZ2/RELM-β Induction and Role in Pulmonary Fibrosis
Liu, T., Baek, H. A., Yu, H., Lee, H. J., Park, B., Ullenbruch, M. R., Liu, J., Nakashima, T., Choi, Y. Y., Wu, G. D., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1000964 · Cited by 72
“Because the Th2 cytokines IL-4 and IL-13 are potent inducers of AEC FIZZ1 expression, and production of IL-17 and IFN-g is upregulated in the lung cells of BLM-treated mice (35, 36), these agents were analyzed for their ability to induce FIZZ2 in these cells using qPCR.”
MethodMacrophage and Innate Lymphoid Cell Interplay in the Genesis of Fibrosis
Hams, E., Bermingham, R., & Fallon, P. G. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00597 · Cited by 75
“IL-17A has been implicated in the generation of fibrosis, with elevated levels detected in patients with IPF and CF (65, 66).”
BackgroundBale, S., Pooladanda, V., Sunkoju, M., & Godugu, C. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00248 · Cited by 73
“Further, inflammatory cytokines including IL-1β, TNF-α, and NF-κB leave no gap in triggering fibrotic events (Wilson et al., 2010; Hou et al., 2018).”
BackgroundIdiopathic Pulmonary Fibrosis: Pathogenesis and the Emerging Role of Long Non-Coding RNAs
Hadjicharalambous, M. R., & Lindsay, M. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020524 · Cited by 75
“Interestingly, the pro-inflammatory cytokine interleukin 17A (IL-17A) which is expressed by CD4+ T-helper (TH-17) cells, has been linked with enhanced neutrophil recruitment, also known as neutrophilia, as well as TGF-dependent and IL-1β-driven fibrosis [51].”
BackgroundTakahashi, T., Asano, Y., Ichimura, Y., Toyama, T., Taniguchi, T., Noda, S., Akamata, K., Tada, Y., Sugaya, M., Kadono, T., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38901 · Cited by 71
“Bleomycin-induced lung fibrosis is IL-17A dependent (46), and IL-17A abrogation leads to decreased dermal fibrosis in the SSc murine models (13).”
Backgroundγδ T Cells Attenuate Bleomycin-Induced Fibrosis through the Production of CXCL10
Pociask, D. A., Chen, K., Choi, S. M., Oury, T. D., Steele, C. H., & Kolls, J. K. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.11.055 · Cited by 75
“Recently, much attention has been given to T cells and their ability to produce IL-17.(16,17) Braun et al(36) showed that T cells are a dominant source of IL-17 and suggested that IL-17 may be involved in epithelial repair responses after bleomycin exposure.”
BackgroundInfluentialA functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis
Huang, Y., Ma, S., Vij, R., Oldham, J. M., Herazo‐Maya, J. D., Broderick, S. M., Strek, M. E., White, S. R., Hogarth, D. K., Sandbo, N. K., et al. (2015) · BMC Pulmonary Medicine · doi:10.1186/s12890-015-0142-8 · Cited by 77
“IL-17A, a cytokine produced by CD4 and gamma-delta T cells, has been shown to play a critical role in inducing fibrosis in a mouse model [30].”
BackgroundDu, C., Zhang, T., Xiao, X., Shi, Y., Duan, H., & Ren, Y. (2017) · Biochemical Journal · doi:10.1042/bcj20170272 · Cited by 68
Pathologic Fibroblasts in Idiopathic Subglottic Stenosis Amplify Local Inflammatory Signals
Morrison, R. J., Katsantonis, N., Motz, K., Hillel, A. T., Garrett, C. G., Netterville, J. L., Wootten, C. T., Majka, S. M., Blackwell, T. S., Drake, W. P., et al. (2018) · Otolaryngology · doi:10.1177/0194599818803584 · Cited by 70
Xu, J., Ma, H.-Y., Liu, X., Rosenthal, S., Baglieri, J., McCubbin, R., Sun, M., Koyama, Y., Geoffroy, C. G., Saijo, K., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.131277 · Cited by 66
A mouse model of chronic idiopathic pulmonary fibrosis
Limjunyawong, N., Mitzner, W., & Horton, M. R. (2014) · Physiological Reports · doi:10.1002/phy2.249 · Cited by 77
“…is perfect, the bleomycin model is a well-established, well-studied, reproducible model of general lung fibrosis that can be interrogated to reveal potential mechanisms underlying human fibrotic lung disorders (Chua et al. 2005; Moeller et al. 2008; Moore and Hogaboam 2008; Wilson et al. 2010).”
BackgroundInterleukin-17: Friend or foe in organ fibrosis
Ramani, K., & Biswas, P. S. (2019) · Cytokine · doi:10.1016/j.cyto.2018.11.003 · Cited by 66
Xiong, S., Guo, R., Yang, Z., Xu, L., Du, L., Li, R., Xiao, F., Wang, Q., Zhu, M., & Pan, X. (2015) · Immunobiology · doi:10.1016/j.imbio.2015.07.001 · Cited by 69
Inflammasomes: Key Mediators of Lung Immunity
Howrylak, J. A., & Nakahira, K. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105229 · Cited by 72
The Role of Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Weng, D., Chen, X., Qiu, H., Zhang, Y., Li, Q., Zhao, M., Wu, Q., Chen, T., Hu, Y., Wang, L.-S., et al. (2019) · Mediators of Inflammation · doi:10.1155/2019/5160694 · Cited by 73
Interleukin-23-Mediated Inflammation in Pseudomonas aeruginosa Pulmonary Infection
Dubin, P. J., Martz, A., Eisenstatt, J. R., Fox, M. D., Logar, A., & Kolls, J. K. (2011) · Infection and Immunity · doi:10.1128/iai.05821-11 · Cited by 68
“prior published literature (18, 28, 61) and on our data that demonstrate”
IL-21 Promotes Pulmonary Fibrosis through the Induction of Profibrotic CD8+ T Cells
Brodeur, T. Y., Robidoux, T. E., Weinstein, J. S., Craft, J. E., Swain, S. L., & Marshak‐Rothstein, A. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500777 · Cited by 79
“This finding was unexpected because CD4+ T cells have been charged with driving fibrosis through the production of IL-17A (10, 18) and IL-13 (11, 12).”
BackgroundInfluentialCD4+ T lymphocytes in lung fibrosis: diverse subsets, diverse functions
Re, S. L., Lison, D., & Huaux, F. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0512261 · Cited by 68
Metadata
- Authors
- Wilson, M. S., Madala, S. K., Ramalingam, T. R., Gochuico, B. R., Rosas, I. O., Cheever, A. W., & Wynn, T. A.
- Affiliations
- National Institutes of Health (US)
- Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115 3
- Biomedical Research Institute (US)
- Corresponding author
- Wynn, Thomas A.
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2010-02-22
- Volume
- 207
- Issue
- 3
- Pages
- 535-552
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2839145
- OpenAlex
- W2095715691
- Cited by
- 730
- References
- 84
- Citations by year
- 2026: 28 · 2025: 39 · 2024: 68 · 2023: 45 · 2022: 47 · 2021: 39 · 2020: 38 · 2019: 51 · 2018: 47 · 2017: 48 · 2016: 42 · 2015: 42 · 2014: 40 · 2013: 57 · 2012: 45
- FWCI
- 41.61
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Keywords
- idiopathic pulmonary fibrosis, IL-17A, bleomycin-induced lung injury, IL-1β, pulmonary fibrosis, TGF-beta, IL-10, interferon-gamma, IL-12/23p40, γδ T cells, CD4+ T cells, neutrophilia, Schistosoma mansoni eggs, bronchoalveolar lavage, IL-17A blockade
- MeSH terms
- Animals, Bleomycin, Interferon-gamma, Lung, Male, Mice, Inbred C57BL, Pulmonary Fibrosis, Schistosoma mansoni, Schistosomiasis mansoni, CD4-Positive T-Lymphocytes, Interleukin-10, Mice, Knockout, Interleukin-13, Interleukin-17, Mice, Interleukin-1beta, Interleukin-12 Subunit p40
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.